Clinical trial
Role of Soy Supplementation in Prostate Cancer Development
NCT00255125 · VA Office of Research and Development, U.S. Fed · Completed
Key facts
| NCT number | NCT00255125 |
|---|---|
| Title | Role of Soy Supplementation in Prostate Cancer Development |
| Official title | Role of Soy Isoflavones in Prostate Cancer Prevention |
| Lead sponsor | VA Office of Research and Development, U.S. Fed |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Prostate Neoplasm |
| Intervention type | Drug |
| Interventions | Soy Supplement, Placebo |
| Enrollment | 86 |
| Start date | Sep 1, 2005 |
| Primary completion | Apr 1, 2009 |
| Completion | Oct 1, 2009 |
| First posted | Nov 17, 2005 |
| Last update posted | Jun 18, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: